Tai, Y., Chang, B. Y., Kong, S., Fulciniti, M., Yang, G., Calle, Y., . . . Anderson, K. C. (2012). Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma. American Society of Hematology.
Citação norma ChicagoTai, Yu-Tzu, et al. Bruton Tyrosine Kinase Inhibition Is a Novel Therapeutic Strategy Targeting Tumor in the Bone Marrow Microenvironment in Multiple Myeloma. American Society of Hematology, 2012.
ציטוט MLATai, Yu-Tzu, et al. Bruton Tyrosine Kinase Inhibition Is a Novel Therapeutic Strategy Targeting Tumor in the Bone Marrow Microenvironment in Multiple Myeloma. American Society of Hematology, 2012.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.